Kips Bay Medical, Inc., a development stage medical device company focused on developing, manufacturing and commercializing external saphenous vein support technology for use in coronary artery bypass grafting, whose shares are listed on the Nasdaq Global Market, closed its initial public offering on February 16, 2011, raising gross proceeds of $16.5 million. Kramer Levin client Rodman & Renshaw LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., acted as sole book-running manager for the offering.

The Kramer Levin team consisted of Corporate partner Christopher S. Auguste and associates Bill Huo, Ari Edelman, Edwin Hermawan and Jennifer A. Wilen, Intellectual Property counsel Kevin M. Moss and Employee Benefits special counsel Avram J. Cahn.

Related People